Back to Journals » OncoTargets and Therapy » Volume 15
Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 [Corrigendum]
Wang J, Li H, Xia C, et al. Onco Targets Ther. 2019;12:869–882.
The authors have advised Figure 2E on page 874 is incorrect. Due to an error at the time of figure assembly NC (24 h) and shCENPK (48 h) in the SMMC-7721 row were inadvertently duplicated. The correct Figure 2 is as follows.
The authors apologize for this error and advise it does not affect the results of the paper.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.